Biogen Licenses Oral C5aR1 Antagonist from Vanqua Bio to Expand Immunology Portfolio Read More » October 24, 2025
Blenrep Approved by US FDA for Use in Treatment of Relapsed Multiple Myeloma Read More » October 24, 2025
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions Read More » October 20, 2025
Roquette Launches Pharma Innovation Center to Boost Latin America as Collaborative Hub Read More » October 16, 2025
